Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

Archived: Previous Version

cobweb icon Archived: Depression in Children and Adolescents: Screening

Original Release Date: March 2009

This version of this topic is currently archived and inactive. It should be used for historical purposes only.

Archived: Recommendation Summary

Summary of Recommendations

(What's This?)
Adolescents, 12-18 years of age, in Clinical Practices with Systems of Care

The USPSTF recommends screening of adolescents (12-18 years of age) for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up. 

Children, 7-11 years of age

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening of children (7-11 years of age).


This recommendation updates the USPSTF's 2002 recommendation on Screening for Depression with respect to children and adolescents. Go to to view the updated recommendation for adults.

Go to the Clinical Considerations section for suggestions for practice when the evidence is insufficient.

Select for a Clinical Summary of this recommendation and suggestions for clinical practice.

Archived: Related Information for Consumers

There is no related information for consumers.

Archived: Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

Current as of: July 2019

Internet Citation: Final Update Summary: Depression in Children and Adolescents: Screening. U.S. Preventive Services Task Force. July 2019.

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857